Urology
Volume 74, Issue 4 , Pages 932-937 , October 2009

Histotripsy of the Prostate: Dose Effects in a Chronic Canine Model

  • Timothy L. Hall

      Affiliations

    • Department of Urology, University of Michigan, Ann Arbor, Michigan
    • Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan
    • Corresponding Author InformationReprint requests: Timothy L. Hall, Ph.D., Department of Urology, University of Michigan, 4432 Med Sci 1, 1301 Catherine St, Ann Arbor, MI 48109
    • ,
  • Christopher R. Hempel

      Affiliations

    • Department of Urology, University of Michigan, Ann Arbor, Michigan
    • Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan
    • ,
  • Kirk Wojno

      Affiliations

    • Department of Urology, University of Michigan, Ann Arbor, Michigan
    • Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan
    • ,
  • Zhen Xu

      Affiliations

    • Department of Urology, University of Michigan, Ann Arbor, Michigan
    • Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan
    • ,
  • Charles A. Cain

      Affiliations

    • Department of Urology, University of Michigan, Ann Arbor, Michigan
    • Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan
    • ,
  • William W. Roberts

      Affiliations

    • Department of Urology, University of Michigan, Ann Arbor, Michigan
    • Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan

Received 19 January 2009 ,Accepted 2 March 2009.

References 

  1. Chute CG, Panser LA, Girman CJ, et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol. 1993;150:85–89
  2. Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol. 2005;173:1256–1261
  3. Mebust WK, Holtgrewe HL, Cockett AT, et al. Transurethral prostatectomy: immediate and postoperative complications (A cooperative study of 13 participating institutions evaluating 3885 patients). J Urol. 1989;141:243–247
  4. Reich O, Gratzke C, Bachmann A, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10, 654 patients. J Urol. 2008;180:246–249
  5. Yu X, Elliot SP, Wilt TJ, et al. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. J Urol. 2008;180:241–245
  6. Tunuguntla HS, Evans CP. Minimally invasive therapies for benign prostatic hyperplasia. World J Urol. 2002;20:197–206
  7. Zlotta AR, Giannakopoulos X, Maehlum O, et al. Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers. Eur Urol. 2003;44:89–93
  8. Elhilali MM. Minimally invasive therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2007;177:820–821
  9. Kieran K, Hall TL, Parsons JE, et al. Refining histotripsy: defining the parameter space for the creation of nonthermal lesions with high intensity, pulsed focused ultrasound of the in vitro kidney. J Urol. 2007;178:672–676
  10. Lake AM, Hall TL, Kieran K, et al. Histotripsy: minimally invasive technology for prostatic tissue ablation in an in vivo canine model. Urology. 2008;72:682–686
  11. Hoffman RM, MacDonald R, Monga M, et al. Transurethral microwave thermotherapy vs transurethral resection for treating benign prostatic hyperplasia: a systematic review. Br J Urol. 2004;94:1031–1036
  12. Hegarty NJ, Gill IS, Desai MM, et al. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation. Urology. 2006;68(suppl 1A):7–13
  13. Kellner DS, Armenakas NA, Brodherson M, et al. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia. Urology. 2004;64:703–706
  14. Minardi D, Garofalo F, Yehia M, et al. Pressure-flow studies in men with benign prostatic hypertrophy before and after treatment with transurethral needle ablation. Urol Int. 2001;66:89–93
  15. Hall TL, Kieran K, Ives K, et al. Histotripsy of rabbit renal tissue in vivo: temporal histologic trends. J Endourol. 2007;21:1159–1166
  16. Hall TL, Fowlkes JB, Cain CA. A real-time measure of cavitation induced tissue disruption by ultrasound imaging backscatter reduction. IEEE Trans Ultrason Ferroelectr Freq Cont. 2007;54:569–575
  17. Häcker A, Köhrmann KU, Back W, et al. Extracorporeal application of high-intensity focused ultrasound for prostatic tissue ablation. BJU Int. 2005;96:71–76

 Supported in part by grants from the Wallace H. Coulter Foundation and NIH 1K08DK081656-01.

PII: S0090-4295(09)00586-X

doi: 10.1016/j.urology.2009.03.049

Urology
Volume 74, Issue 4 , Pages 932-937 , October 2009

Article Tools

* Image Usage & Resolution